Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:677-681
Published online before print January 29, 2004, doi: 10.1161/01.STR.0000116876.96334.82
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/3/677    most recent
01.STR.0000116876.96334.82v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamagami, H.
Right arrow Articles by Hori, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamagami, H.
Right arrow Articles by Hori, M.
Related Collections
Right arrow Carotid Stenosis
Right arrow Other imaging
Right arrow Risk Factors for Stroke

(Stroke. 2004;35:677.)
© 2004 American Heart Association, Inc.


Original Contributions

Higher Levels of Interleukin-6 Are Associated With Lower Echogenicity of Carotid Artery Plaques

Hiroshi Yamagami, MD; Kazuo Kitagawa, MD, PhD; Yoji Nagai, MD, PhD; Hidetaka Hougaku, MD, PhD; Manabu Sakaguchi, MD; Keisuke Kuwabara, MD, PhD; Kimito Kondo, MD; Tohru Masuyama, MD, PhD; Masayasu Matsumoto, MD, PhD Masatsugu Hori, MD, PhD

From the Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Suita (H.Y., K. Kitagawa, Y.N., H.H., K. Kondo, T.M., M.H.); Department of Neurology, Kobe City General Hospital, Kobe (M.S.); Nishizawa Medical Office, Osaka (K. Kuwabara); and Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical Science, Hiroshima (M.M.), Japan.

Correspondence to Hiroshi Yamagami, MD, Department of Internal Medicine and Therapeutics (A8), Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan. E-mail yamagami{at}medone.med.osaka-u.ac.jp

Background and Purpose— Echo-lucent carotid plaques can be fragile and vulnerable to rupture, representing a risk factor for ischemic stroke. Given the studies showing that elevated levels of circulating inflammatory markers are predictive of cardiovascular events, we sought to determine whether higher levels of serum interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hsCRP) are associated with lower echogenicity of carotid plaques.

Methods— The study comprised 246 patients who had carotid atherosclerotic plaques as evidenced by ultrasound. Using acoustic densitometry, we quantified the echogenicity of the largest plaque in each patient by integrated backscatter analysis. Serum IL-6 and hsCRP levels were determined in all patients.

Results— Both log-transformed IL-6 and hsCRP concentrations were negatively correlated with carotid plaque echogenicity (r=-0.28, P<0.001, and r=-0.14, P<0.05, respectively). When traditional atherosclerotic risk factors, plaque thickness, and medication use were controlled for, IL-6 levels were inversely associated with plaque echogenicity (ß=-0.21, P<0.01), whereas such an association was of borderline significance for hsCRP (ß=-0.12, P=0.06).

Conclusions— Higher IL-6 levels, in addition to hsCRP levels, appear to be associated with lower echogenicity of carotid plaques, suggesting a link between inflammation and potential risk of plaques.


Key Words: atherosclerosis • carotid arteries • inflammation • interleukins • ultrasonography




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
K. Watanabe, S. Sugiyama, K. Kugiyama, O. Honda, H. Fukushima, H. Koga, Y. Horibata, T. Hirai, T. Sakamoto, M. Yoshimura, et al.
Stabilization of Carotid Atheroma Assessed by Quantitative Ultrasound Analysis in Nonhypercholesterolemic Patients With Coronary Artery Disease
J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2022 - 2030.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Di Napoli, M. Schwaninger, R. Cappelli, E. Ceccarelli, G. Di Gianfilippo, C. Donati, H. C.A. Emsley, S. Forconi, S. J. Hopkins, L. Masotti, et al.
Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke: A Statement for Health Care Professionals From the CRP Pooling Project Members
Stroke, June 1, 2005; 36(6): 1316 - 1329.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. B. Kritchevsky, M. Cesari, and M. Pahor
Inflammatory markers and cardiovascular health in older adults
Cardiovasc Res, May 1, 2005; 66(2): 265 - 275.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Hoshi, K. Kitagawa, H. Yamagami, S. Furukado, H. Hougaku, and M. Hori
Relations of Serum High-Sensitivity C-Reactive Protein and Interleukin-6 Levels With Silent Brain Infarction
Stroke, April 1, 2005; 36(4): 768 - 772.
[Abstract] [Full Text] [PDF]